China National Medicines Corporation Ltd. (SHSE: 600511)
Health Care · Health Care Providers & Services · CN
CN¥26.67
+2.18% today · -7.4% 1Y
China National Medicines Corporation Ltd. (SHSE: 600511) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $3.00B and employs 3,024 people.
Over the last twelve months the share price has lost 7.4%, trading between 25.11 and 31.18.
Tweenvest scores China National Medicines Corporation Ltd. across four factors: quality 81/100, value 73/100, growth 42/100, dividend 73/100. Its strongest factor is quality.
600511 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.00B
- Revenue (TTM)
- $7.89B
- P/E
- 10.44
- EPS
- 2.55
- Dividend yield
- 3.00%
- Beta (5Y)
- 0.13
- 52-week high
- CN¥31.18
- 52-week low
- CN¥25.11
- Avg volume (3M)
- —
- Shares outstanding
- 754.50M
- Employees
- 3,024
- Next earnings
- —
About China National Medicines Corporation Ltd.
China National Medicines Corporation Ltd., in conjunction with its various operating entities, is a prominent player in the distribution of pharmaceutical goods across China. The enterprise's scope extends to the production and commercialization of innovative as well as pre-existing drug formulations. Additionally, it markets both traditional Chinese patent remedies and modern Western medications, alongside a range of medical apparatus. Complementing these activities, the firm delivers warehousing solutions and acts as an agent for import and export transactions. Its diverse clientele encompasses hospitals, retail pharmacies, and other healthcare organizations. Established in 1999, the company maintains its principal office in Beijing, China.
- ISIN
- CNE000001D56
- Founded
- 1999
- Listed since
- Nov 27, 2002
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| National HealthCare CorporationNYSEAM: NHC | $3.56B | $227.11 | +0.86% |
| Dr. Lal PathLabs LimitedNSEI: LALPATHLAB | $3.34B | Rs1,933.60 | -3.57% |
| Mouwasat Medical Services CompanySASE: 4002 | $3.30B | SR62.00 | -1.12% |
| Fleury S.A.BOVESPA: FLRY3 | $3.03B | R$27.73 | +18.00% |
| Krishna Institute of Medical Sciences LimitedNSEI: KIMS | $2.92B | Rs705.50 | -4.18% |
| Meinian Onehealth Healthcare Holdings Co., Ltd.SZSE: 002044 | $2.85B | CN¥4.90 | +7.93% |
| Hanmi Science Co., Ltd.KOSE: A008930 | $2.77B | ₩54,900.00 | -0.72% |
| Acadia Healthcare Company, Inc.NasdaqGS: ACHC | $2.72B | $29.25 | +2.70% |
Figures last refreshed Oct 11, 2026.